-
Expand Harm Reduction Services to Address Impact of Overdose Crisis on Older Adults
The devastating impact of the overdose crisis in the United States has been well-documented, affecting people from all backgrounds, demographics, and geographic regions. The data tells us that one age group in particular has been overlooked in the overdose crisis – older adults. The rate...
-
Only 1 in 5 U.S. Adults With Opioid Use Disorder Received Medications to Treat It in 2021
In 2021, an estimated 2.5 million people aged 18 years or older in the U.S. had opioid use disorder in the past year, yet only 1 in 5 of them (22%) received medications to treat it, according to a new study. Some groups were substantially less likely to receive medication, including Black adults,...
-
Higher Buprenorphine Doses Associated With Improved Retention in Treatment for Opioid Use Disorder
Individuals with opioid use disorder who were prescribed a lower buprenorphine dose were 20% more likely to discontinue treatment than those on a higher dose, according to a study of patients prescribed buprenorphine in Rhode Island from 2016 to 2020, as fentanyl became widely available. The...
-
Telehealth Supports Retention in Treatment for Opioid Use Disorder
Starting buprenorphine treatment for opioid use disorder through telehealth was associated with an increased likelihood of staying in treatment longer compared to starting treatment in a non-telehealth setting, according to a new study analyzing Medicaid data from 2019-2020 in Kentucky and Ohio....
-
Only 1 in 4 Adolescent Treatment Facilities Offer Buprenorphine for Opioid Use Disorder
Only 1 in 4 residential addiction treatment facilities caring for U.S. adolescents under 18 years old offer buprenorphine, a medication used to treat opioid use disorder, according to a new study. Only 1 in 8 offer buprenorphine for ongoing treatment. These findings highlight a significant gap in...
-
Increased Use of Telehealth for OUD Services During COVID-19 Pandemic Associated With Reduced Risk of Overdose
The expansion of telehealth services for opioid use disorder (OUD) during the COVID-19 pandemic was associated with individuals staying in treatment longer and reducing their risk of medically treated overdose, according to a new study. Published today in JAMA Psychiatry, this study was a...
-
Buprenorphine Initiation in the ER Found Safe and Effective for Individuals With Opioid Use Disorder Who Use Fentanyl
Results from a multi-site clinical trial supported by the National Institutes of Health showed that less than 1% of people with opioid use disorder whose drug use includes fentanyl experienced withdrawal when starting buprenorphine in the ER. The findings, which appeared today in JAMA Network Open,...
-
NIH Research Matters – Telehealth Improves Treatment for Opioid Use Disorder
Telehealth improves treatment for opioid use disorder for people during the COVID-19 pandemic, increasing the likelihood of staying on their medications and less likely to overdose. The findings support continuing the expanded telehealth access that began during the pandemic. Medications...
-
Behavioral Health News Spotlight on Excellence: An Interview with Mary Brewster, Associate Commissioner for Harm Reduction at the New York State Office of Addiction Services and Supports (OASAS)
Overview David Minot, Executive Director of Mental Health News Education, the non-profit organization that publishes Behavioral Health News, interviewed Mary Brewster, Associate Commissioner for Harm Reduction at the New York State Office of Addiction Services and Supports (OASAS). The mission of...
-
The NYSPA Report: Overdose Prevention Centers Keep Our People Alive
People with opioid use disorder (OUD) have a high prevalence of a serious mental illness (SMI). Nearly 27% of people with an OUD had a co-occurring SMI (Jones and McCance-Katz 2019), which complicates care when access to dual diagnosis treatment is limited. Overdose deaths have steadily increased...
